Major Children's Hospitals Cease Gender-Affirming Care Following Federal Pressure

Children's Hospital Los Angeles has stopped treating transgender patients and ceased providing gender-affirming care, joining a growing list of major pediatric medical centers that have shuttered their programs since the Trump administration began threatening federal funding for institutions that provide such services to minors.

The Verge reports that the Los Angeles facility, which previously provided comprehensive gender-affirming care including treatment for hormonal imbalances and related mental health support, formally closed its Center for Transyouth Health and Development on July 22, 2025. The closure followed federal pressure campaigns targeting pediatric gender care providers.

Coordinated Program Shutdowns

Kaiser Permanente, described as one of the largest providers of healthcare for trans people in California, suspended surgical gender-affirming care for patients under 19 across its hospitals and surgical centers. The health system's decision reflects a pattern emerging across major pediatric facilities as federal enforcement actions intensify.

Connecticut Children's Medical Center shut down its gender-affirming health care program for transgender and gender-diverse patients, explicitly citing pressure from the Trump administration as a contributing factor. Rady Children's Hospital closed its Center for Gender-Affirming Care effective February 6, 2026, representing California's largest children's hospital system ending hormone therapy provision for those under 19.

The scope extends beyond voluntary program closures. Texas Children's Hospital in Houston faces a federal requirement to create a detransition clinic for transgender patients, marking a shift toward mandated reversal services rather than affirming care.

Federal Enforcement Mechanisms

The Trump administration has deployed multiple regulatory and legal mechanisms to restrict pediatric gender care access. The Department of Health and Human Services unveiled regulatory actions to block gender-affirming care for minors, with RFK Jr. and Dr. Mehmet Oz announcing the restrictions at HHS headquarters. Oz, who leads Medicaid and Medicare under the current administration, oversees the implementation of two new proposed rules targeting federal funding streams.

The federal approach centers on financial pressure: cutting off Medicaid and Medicare funding from hospitals that provide gender-affirming care to children, while prohibiting federal Medicaid dollars from funding gender-affirming procedures for minors. These restrictions would imperil access in nearly two dozen states where such treatments remain legal and funded by Medicaid.

Beyond funding threats, the administration has pursued direct legal action. The Department of Justice initially demanded that Los Angeles hospital systems turn over transgender minors' medical records, though it later withdrew this demand following legal challenges. A judge rejected the DOJ's subpoena to Children's Hospital Colorado, where the state Supreme Court subsequently ruled that the facility must resume offering gender-affirming care to transgender youth.

Clinical and Legal Resistance

Some parents in Los Angeles have expressed concern that the DOJ will use subpoenaed private medical data from pediatric hospitals to remove children from their families, reflecting broader fears about federal overreach into family medical decisions.

The medical establishment has maintained its position supporting evidence-based care. The American Academy of Pediatrics published policy statements ensuring comprehensive care and support for transgender children and adolescents. The Endocrine Society stated that NHS England's Cass Review contains no new research contradicting their Clinical Practice Guideline recommendations on gender-affirming care, and the organization is updating its 2017 guidelines.

Research data cited by medical organizations indicates that transgender individuals denied care show increased likelihood of suicide and self-harm, while transgender youth with access to pubertal suppression demonstrate lower lifetime odds of suicidal ideation compared to those who desired but could not access treatment. Studies suggest 70% of transgender individuals have experienced medical provider maltreatment, including harassment and violence.

Broader Context and Precedent

We have seen this pattern before, when federal agencies used funding leverage to reshape state healthcare delivery during the Reagan era's HIV response and later during debates over emergency contraception access. The current approach follows a familiar playbook: threaten core funding streams, pursue legal action against individual institutions, and create enough regulatory uncertainty to prompt voluntary compliance.

Conversion therapy efforts remain banned in 20 states and the District of Columbia, with research linking such interventions to adverse mental health outcomes including increased suicidality. The current federal restrictions effectively create a parallel system of mandated program closures while avoiding direct prohibition of state-legal medical practices.

Implementation Challenges

The federal funding restrictions create operational complexities for health systems that serve diverse patient populations. Large integrated systems like Kaiser Permanente must now segregate pediatric gender care from other services to maintain federal reimbursements, potentially fragmenting care delivery for transgender youth who often require coordinated medical, mental health, and social support services.

The regulatory uncertainty has prompted some institutions to preemptively close programs rather than navigate evolving compliance requirements. This defensive posture reflects broader healthcare sector concerns about federal oversight expanding beyond traditional regulatory boundaries into clinical practice standards.

As enforcement mechanisms take effect across multiple states, the landscape for pediatric gender care continues shifting toward a patchwork system where access depends heavily on geographic location, institutional risk tolerance, and state-level legal protections. The long-term implications for both medical practice standards and federalism principles in healthcare delivery remain to be determined as legal challenges work through federal courts.